MYRIAD GENETICS, INC. MYGN Income Statement

Myriad genetics, inc. (MYGN)

Income statement / TTM

Mar'20	Dec'19	Sep'19	Jun'19	Mar'19	Dec'18	Sep'18	Jun'18	Mar'18	Dec'17	Sep'17	Jun'17	Mar'17	Dec'16	Sep'16	Jun'16	Mar'16	Dec'15	Sep'15	Jun'15	Mar'15	Dec'14	Sep'14	Jun'14	Mar'14	Dec'13	Sep'13	Jun'13	Mar'13	Dec'12	Sep'12	Jun'12	Mar'12	Dec'11	Sep'11	Jun'11	Mar'11	Dec'10	Sep'10	Jun'10	Mar'10	Dec'09	Sep'09
Total revenue
760,800	813,400	835,100	851,100	829,600	796,100	767,200	743,700	749,400	761,000	769,800	768,500	742,100	737,900	734,500	740,500	757,200	746,700	737,800	723,100	721,949	724,873	744,533	778,200	763,602	737,150	682,230	613,200	572,014	545,319	518,990	496,005	470,452	443,049	420,678	402,084	388,600	377,056	369,384	362,648	0	0	0
Costs and expenses:
Research and development expense
80,700	82,500	86,100	85,900	82,700	79,700	74,100	70,800	71,900	71,000	72,800	74,400	75,100	74,700	72,800	70,600	69,800	69,300	70,100	75,500	77,010	73,707	73,297	67,500	61,865	62,086	59,103	53,700	51,269	49,404	45,540	42,645	39,731	34,645	30,494	27,751	23,774	22,992	21,959	21,873	0	0	0
Change in the fair value of contingent consideration
-3,100	300	1,400	1,100	1,600	400	12,400	-61,200	-64,100	-57,700	-74,500	-800	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Selling, general, and administrative expense
553,800	561,500	561,100	555,500	518,200	485,500	457,700	435,000	444,600	458,800	471,700	476,400	445,700	414,100	384,600	359,200	364,400	365,200	367,100	366,000	353,750	350,081	335,221	327,100	314,257	291,228	272,951	251,800	236,876	226,974	218,397	208,383	195,681	183,731	176,461	169,841	165,758	163,848	162,236	161,414	0	0	0
Goodwill and intangible asset impairment charges
0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total costs and expenses
929,800	842,800	849,600	843,500	798,600	757,200	728,100	621,800	626,400	646,300	644,200	721,200	691,400	650,100	618,700	587,100	589,800	586,200	586,200	588,900	570,839	554,176	527,137	503,800	476,498	447,415	419,908	385,200	362,643	347,770	331,562	315,687	295,642	272,511	257,019	244,306	234,983	232,038	228,430	227,573	0	0	0
Operating income (loss)
-169,000	-29,400	-14,500	7,600	31,000	38,900	39,100	121,900	123,000	114,700	125,600	47,300	50,700	87,800	115,800	153,400	167,400	160,500	151,600	134,200	151,110	170,697	217,396	274,400	287,104	289,735	262,322	228,000	209,371	197,549	187,428	180,318	174,810	170,538	163,659	157,778	153,617	145,018	140,954	135,075	0	0	0
Other income (expense):
Interest income
3,400	3,300	3,400	3,200	2,800	2,600	2,100	1,800	1,600	1,400	1,300	1,200	1,300	1,300	1,100	900	600	400	400	400	510	2,908	4,138	5,400	6,503	5,439	5,494	5,500	5,582	5,527	5,524	4,629	3,644	2,812	1,978	2,226	2,800	3,485	4,468	5,660	0	0	0
Interest expense
10,900	11,800	12,700	12,000	9,900	7,200	4,500	3,200	3,300	4,300	6,200	6,000	4,900	0	0	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-278	-343	-359	-353	-80	-44	-250	99	0	0	0
Other
4,000	-200	700	1,200	1,800	1,400	1,000	-400	-1,300	700	-1,500	-2,500	-500	-1,800	600	2,000	-700	-1,200	500	300	166	24	-1,661	-2,000	-2,409	-2,078	-1,879	-200	0	0	0	-	-	-	-	-	-	-	-	-	0	0	0
Total other income (expense):
-3,500	-8,700	-8,600	-7,600	-5,300	-3,200	-1,400	-1,800	-3,000	-2,200	-6,400	-7,300	-4,200	-4,000	700	2,600	300	1,400	0	-	0	0	-	3,400	5,447	4,790	0	-	0	0	-	4,222	0	0	0	-	0	0	0	-	-	-	-
Income (loss) before income tax
-172,500	-38,100	-23,100	0	25,700	35,700	37,700	120,100	120,000	112,500	119,200	40,000	46,500	83,800	116,500	156,000	167,200	159,600	152,500	134,900	151,786	173,629	219,873	277,800	292,566	294,464	267,305	233,300	214,519	202,759	192,557	184,540	178,176	173,007	165,278	159,651	156,149	148,317	145,602	140,834	0	0	0
Income tax provision (benefit)
-24,100	-11,800	-7,700	-4,400	2,500	10,400	-15,900	-13,000	-10,700	-12,000	19,500	20,200	23,500	29,100	30,800	38,800	46,500	52,000	58,000	54,700	56,781	63,254	83,138	101,600	105,835	106,611	94,776	86,100	82,314	78,831	75,369	72,389	69,125	65,631	62,007	58,941	28,229	15,086	1,203	-11,469	0	0	0
Net income (loss)
-148,400	-26,300	-15,400	4,400	23,200	25,300	53,600	133,100	130,700	124,500	99,700	19,800	23,000	54,700	85,700	117,200	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net loss attributable to non-controlling interest
-	-	-	-200	-100	-200	-200	-200	-400	0	0	0	-	-	-	-	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net income (loss) attributable to Myriad Genetics, Inc. stockholders
-148,300	-26,200	-15,300	4,600	23,300	25,500	53,800	133,300	131,100	124,800	100,000	20,000	23,000	54,700	85,700	117,200	120,700	107,600	94,500	80,200	95,005	110,375	136,735	176,200	186,731	187,853	172,529	147,200	132,205	123,928	117,188	112,151	109,051	107,376	103,271	100,710	127,920	133,231	144,399	152,303	0	0	0
Earnings (loss) per share:
Basic
-1.55	-0.11	-0.28	-0.06	0.09	0.04	-0.01	0.21	0.13	0.45	1.15	0.18	0.04	0.09	-0.02	0.21	0.49	0.53	0.44	0.27	0.30	0.33	0.22	0.46	0.50	0.67	0.70	0.55	0.47	0.43	0.37	0.36	0.35	0.33	0.29	0.30	0.32	0.26	0.24	0.55	0.34	0.37	0.32
Diluted
-1.55	-0.11	-0.28	-0.06	0.09	0.03	-0.01	0.20	0.13	0.43	1.12	0.18	0.04	0.09	-0.02	0.21	0.47	0.50	0.42	0.26	0.29	0.32	0.21	0.43	0.48	0.66	0.68	0.53	0.46	0.42	0.36	0.34	0.34	0.33	0.29	0.29	0.31	0.26	0.24	0.54	0.33	0.36	0.31
Weighted average shares outstanding:
Basic
74,500	74,400	73,700	73,400	73,300	74,200	73,000	70,100	69,800	69,300	68,600	68,200	68,100	68,200	68,800	69,900	70,900	70,500	68,700	69,200	70,700	72,500	72,800	74,334	73,821	75,070	79,575	79,961	80,375	81,692	81,572	84,290	84,403	84,498	85,241	86,179	88,206	91,528	93,263	96,259	96,853	96,270	95,970
Diluted
74,500	74,400	73,700	74,800	74,900	76,500	73,000	72,900	72,400	71,900	70,400	68,900	68,300	68,300	68,800	74,200	73,500	73,800	72,100	72,600	73,900	75,400	76,100	77,803	76,374	76,825	81,798	82,612	82,434	84,240	83,914	86,130	86,462	86,231	87,037	88,308	90,127	93,647	94,734	98,016	99,674	99,426	99,492
Net income
-148,300	-26,200	-15,300	4,600	23,300	25,500	53,800	133,300	131,100	124,800	100,000	20,000	0	0	0	-	-	-	-	-	-	-	-	-	0	0	0	-	132,205	123,928	117,188	112,151	109,051	107,376	103,271	100,710	127,920	133,231	144,399	152,303	0	0	0
Comprehensive income:
Unrealized gain (loss) on available-for-sale securities, net of tax
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	-	335	16	0	-	0	0	-	-	-	-	-	-	-	-	-
Change in foreign currency translation adjustment, net of tax
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	-	-478	-61	0	-	0	0	-	-	-	-	-	-	-	-	-
Comprehensive income
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	-	131,845	123,960	117,430	111,838	0	0	0	-	-	-	-	-	-	-	-
Molecular Diagnostic Testing [Member]
Total revenue
700,500	750,500	772,400	789,400	773,100	741,900	712,000	690,400	696,800	710,500	721,500	719,200	692,700	687,100	685,600	692,400	710,700	706,300	702,900	695,500	699,564	702,755	719,713	748,200	731,433	703,626	648,119	582,400	543,802	518,730	495,689	472,390	450,265	429,327	412,157	400,046	0	0	0	-	-	-	-
Total costs and expenses
166,900	164,100	167,100	168,200	164,600	161,100	154,800	148,700	146,300	147,400	147,100	145,200	143,800	139,500	136,200	132,800	130,500	129,900	130,900	132,800	129,158	119,806	107,461	96,100	86,282	79,096	71,907	64,400	59,832	56,835	54,084	51,452	49,027	46,695	45,926	45,637	45,451	45,198	44,235	44,286	0	0	0
Pharmaceutical and Clinical Services [Member]
Total revenue
60,300	62,900	62,700	61,700	56,500	54,200	55,200	53,300	52,600	50,500	48,300	49,300	49,400	50,800	48,900	48,100	46,500	40,400	34,900	27,600	22,385	22,118	24,820	30,000	32,169	33,524	34,111	30,800	28,212	26,589	23,301	23,615	0	0	0	-	-	-	-	-	-	-	-
Total costs and expenses
33,100	34,400	33,900	32,800	31,500	30,500	29,100	28,500	27,700	26,800	27,100	26,000	24,900	25,100	24,600	24,500	25,100	21,800	18,100	14,600	10,921	10,582	11,158	13,100	14,094	15,005	15,947	15,300	14,666	14,557	13,541	13,207	0	0	0	-	-	-	-	-	-	-	-